Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John H Griffin

Showing results (1-10 of 203) with videos related to

Pageof 21
Sort By:
Research and Practice in Thrombosis and Haemostasis|June 18, 2020
COVID-19 hypothesis: Activated protein C for therapy of virus-induced pathologic thromboinflammationJohn H Griffin, Patrick Lyden
Blood Cells, Molecules & Diseases|December 20, 2002
Activated protein C-dependent and -independent anticoagulant activities of protein S have different structural requirementsMary J Heeb, John H Griffin
Proteins|January 30, 2004
Characterization of a thrombomodulin binding site on protein C and its comparison to an activated protein C binding site for factor VaAndrew J Gale, John H Griffin
Biochemistry|June 26, 2002
Conversion of a plant oxidosqualene-cycloartenol synthase to an oxidosqualene-lanosterol cyclase by random mutagenesisTung-Kung Wu, John H Griffin
The Biochemical Journal|April 10, 2003
Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptorLaurent O Mosnier, John H Griffin
Inorganic Chemistry|August 14, 1996
Steric and Electronic Effects, Enantiospecificity, and Reactive Orientation in DNA Binding/Cleaving by Substituted Derivatives of [SalenMn(III)](+)Dennis J. Gravert, John H. Griffin
Frontiers in Bioscience : a Journal and Virtual Library|May 25, 2006
Protein C anticoagulant activity in relation to anti-inflammatory and anti-apoptotic activitiesLaurent O Mosnier, John H Griffin
Trends in Neurosciences|March 1, 2011
Cytoprotective protein C pathways and implications for stroke and neurological disordersBerislav V Zlokovic, John H Griffin
Bioorganic & Medicinal Chemistry Letters|June 12, 2003
EnantiotracinPatrick G McDougal, John H Griffin
The Journal of Biological Chemistry|February 1, 2003
Glucosylceramide, a neutral glycosphingolipid anticoagulant cofactor, enhances the interaction of human- and bovine-activated protein C with negatively charged phospholipid vesiclesSubramanian Yegneswaran, Hiroshi Deguchi, John H Griffin
Pageof 21

Showing results (1-10 of 203) with videos related to

Sort By:
Pageof 21
Research and Practice in Thrombosis and Haemostasis|June 18, 2020
COVID-19 hypothesis: Activated protein C for therapy of virus-induced pathologic thromboinflammationJohn H Griffin, Patrick Lyden
Blood Cells, Molecules & Diseases|December 20, 2002
Activated protein C-dependent and -independent anticoagulant activities of protein S have different structural requirementsMary J Heeb, John H Griffin
Proteins|January 30, 2004
Characterization of a thrombomodulin binding site on protein C and its comparison to an activated protein C binding site for factor VaAndrew J Gale, John H Griffin
Biochemistry|June 26, 2002
Conversion of a plant oxidosqualene-cycloartenol synthase to an oxidosqualene-lanosterol cyclase by random mutagenesisTung-Kung Wu, John H Griffin
The Biochemical Journal|April 10, 2003
Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptorLaurent O Mosnier, John H Griffin
Inorganic Chemistry|August 14, 1996
Steric and Electronic Effects, Enantiospecificity, and Reactive Orientation in DNA Binding/Cleaving by Substituted Derivatives of [SalenMn(III)](+)Dennis J. Gravert, John H. Griffin
Frontiers in Bioscience : a Journal and Virtual Library|May 25, 2006
Protein C anticoagulant activity in relation to anti-inflammatory and anti-apoptotic activitiesLaurent O Mosnier, John H Griffin
Trends in Neurosciences|March 1, 2011
Cytoprotective protein C pathways and implications for stroke and neurological disordersBerislav V Zlokovic, John H Griffin
Bioorganic & Medicinal Chemistry Letters|June 12, 2003
EnantiotracinPatrick G McDougal, John H Griffin
The Journal of Biological Chemistry|February 1, 2003
Glucosylceramide, a neutral glycosphingolipid anticoagulant cofactor, enhances the interaction of human- and bovine-activated protein C with negatively charged phospholipid vesiclesSubramanian Yegneswaran, Hiroshi Deguchi, John H Griffin
Pageof 21